HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two.

Abstract
Endocannabinoids (eCBs) and glucocorticoids (GCs) are two distinct classes of signaling lipids that exert both neuroprotective and immunosuppressive effects; however, the possibility of an actual interaction of their receptors [i.e., type-2 cannabinoid (CB2) and glucocorticoid receptor α (GRα), respectively] remains unexplored. Here, we demonstrate that the concomitant activation of CB2 and GRα abolishes the neuroprotective effects induced by each receptor on central neurons and on glial cells in animal models of remote cell death. We also show that the ability of eCBs and GCs, used individually, to inhibit tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) production from activated human T lymphocytes is lost when CB2 and GRα are activated simultaneously. In addition, signal transduction pathways triggered by concomitant activation of both receptors led to increased levels of GRβ, heat-shock proteins-70 and -90, and p-JNK, as well as to reduced levels of p-STAT6. These effects were reversed only by selectively antagonizing CB2, but not GRα. Overall, our study demonstrates for the first time the existence of a CB2-driven negative cross-talk between eCB and GC signaling in both rats and humans, thus paving the way to the possible therapeutic exploitation of CB2 as a new target for chronic inflammatory and neurodegenerative diseases.
AuthorsElisa Bisicchia, Valerio Chiurchiù, Maria Teresa Viscomi, Laura Latini, Filomena Fezza, Luca Battistini, Mauro Maccarrone, Marco Molinari
JournalCellular and molecular life sciences : CMLS (Cell Mol Life Sci) Vol. 70 Issue 12 Pg. 2191-204 (Jun 2013) ISSN: 1420-9071 [Electronic] Switzerland
PMID23296125 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endocannabinoids
  • Glucocorticoids
  • Receptor, Cannabinoid, CB2
  • Receptors, Glucocorticoid
  • Tumor Necrosis Factor-alpha
  • glucocorticoid receptor alpha
  • Interferon-gamma
Topics
  • Analysis of Variance
  • Animals
  • Blotting, Western
  • Endocannabinoids (metabolism)
  • Flow Cytometry
  • Glucocorticoids (metabolism)
  • Humans
  • Immunohistochemistry
  • Immunoprecipitation
  • Interferon-gamma (metabolism)
  • Male
  • Neuroglia (metabolism)
  • Neurons (metabolism)
  • Rats
  • Rats, Wistar
  • Receptor Cross-Talk (physiology)
  • Receptor, Cannabinoid, CB2 (metabolism)
  • Receptors, Glucocorticoid (metabolism)
  • Signal Transduction (physiology)
  • T-Lymphocytes (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: